{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:18:53Z","timestamp":1794647933892,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ5894"],"award-info":[{"award-number":["2020JJ5894"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701621"],"award-info":[{"award-number":["81701621"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901664"],"award-info":[{"award-number":["81901664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.metabol.2023.155587","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T19:02:21Z","timestamp":1683399741000},"page":"155587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis"],"prefix":"10.1016","volume":"144","author":[{"given":"Muyao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg H.W.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.metabol.2023.155587_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.metabol.2023.155587_bb0015","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2013-203618","article-title":"Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria","volume":"73","author":"Andreasson","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.metabol.2023.155587_bb0020","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.metabol.2023.155587_bb0025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/BOR.0000000000000644","article-title":"T and B lymphocytes in fibrosis and systemic sclerosis","volume":"31","author":"Pillai","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.metabol.2023.155587_bb0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/annrheumdis-2021-220209","article-title":"Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis","volume":"80","author":"Gaydosik","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.metabol.2023.155587_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102526","article-title":"Bi-directional communication: conversations between fibroblasts and immune cells in systemic sclerosis","volume":"113","author":"Worrell","year":"2020","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.metabol.2023.155587_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/BOR.0000000000000657","article-title":"Macrophages and cadherins in fibrosis and systemic sclerosis","volume":"31","author":"To","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0045","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1038\/s41467-021-24601-y","article-title":"TGFbeta promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy","volume":"12","author":"Zehender","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2015.154","article-title":"Canonical wnt signaling in systemic sclerosis","volume":"96","author":"Bergmann","year":"2016","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.metabol.2023.155587_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","article-title":"JAK inhibitors: prospects in connective tissue diseases","volume":"59","author":"You","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jid.2018.08.021","article-title":"Notch signaling activity determines uptake and biological effect of imatinib in systemic sclerosis dermal fibroblasts","volume":"139","author":"Harrach","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.metabol.2023.155587_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.metabol.2018.12.004","article-title":"The role of metabolism in the pathogenesis of systemic sclerosis","volume":"93","author":"Zhu","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155587_bb0070","article-title":"Lipid metabolism profiles in rheumatic diseases","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BOR.0000000000000824","article-title":"Metabolic perturbations in systemic sclerosis","volume":"34","author":"O'Reilly","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"23","key":"10.1016\/j.metabol.2023.155587_bb0080","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.1111\/jcmm.16013","article-title":"Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis","volume":"24","author":"Henderson","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2023.155587_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155346","article-title":"Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity","volume":"138","author":"Angelidi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155587_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154922","article-title":"Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry","volume":"126","author":"Spick","year":"2022","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.metabol.2023.155587_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030607","article-title":"Plasma metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis","volume":"10","author":"Bogl","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0100","doi-asserted-by":"crossref","first-page":"21912","DOI":"10.1038\/s41598-020-78951-6","article-title":"Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease","volume":"10","author":"Meier","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2023.155587_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","article-title":"Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension","volume":"241","author":"Deidda","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0110","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1038\/s41598-018-25992-7","article-title":"Metabolomic profile of systemic sclerosis patients","volume":"8","author":"Murgia","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.metabol.2023.155587_bb0115","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-015-0721-3","article-title":"Nilotinib (Tasigna) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial","volume":"17","author":"Gordon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.metabol.2023.155587_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/rheumatology\/keh070","article-title":"The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma","volume":"43","author":"Sultan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41467-019-09101-4","article-title":"Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.metabol.2023.155587_bb0135","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2023.155587_bb0140","first-page":"10","article-title":"The fibrosis and immunological features of hypochlorous acid induced mouse model of systemic sclerosis","volume":"2019","author":"Meng","year":"1861","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.metabol.2023.155587_bb0145","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/jcsm.13045","article-title":"Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes","volume":"13","author":"Liu","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2023.155587_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155140","article-title":"Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men","volume":"129","author":"Hajishafiee","year":"2022","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.metabol.2023.155587_bb0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"issue":"14","key":"10.1016\/j.metabol.2023.155587_bb0165","article-title":"COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status","volume":"5","author":"Thomas","year":"2020","journal-title":"JCIInsight"},{"key":"10.1016\/j.metabol.2023.155587_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jep.2019.01.041","article-title":"Fructus gardeniae-induced gastrointestinal injury was associated with the inflammatory response mediated by the disturbance of vitamin B6, phenylalanine, arachidonic acid, taurine and hypotaurine metabolism","volume":"235","author":"Zhou","year":"2019","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"10.1016\/j.metabol.2023.155587_bb0175","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.41733","article-title":"Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout","volume":"73","author":"Shen","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.metabol.2023.155587_bb0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00726-021-03020-9","article-title":"Methionine sulfoxide and the methionine sulfoxide reductase system as modulators of signal transduction pathways: a review","volume":"53","author":"Moskovitz","year":"2021","journal-title":"Amino Acids"},{"key":"10.1016\/j.metabol.2023.155587_bb0185","first-page":"8","article-title":"The importance of methionine metabolism","author":"Klein Geltink","year":"2019","journal-title":"elife"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.metabol.2023.155587_bb0195","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.ajpath.2021.06.010","article-title":"Methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis is associated with increased intestinal inflammation","volume":"191","author":"Matthews","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2023.155587_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2019.01.043","article-title":"Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt\/mTOR signaling in methionine-choline deficiency-induced fatty liver disease","volume":"848","author":"Veskovic","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"6527","key":"10.1016\/j.metabol.2023.155587_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.metabol.2023.155587_bb0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.metabol.2023.155587_bb0215","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","article-title":"Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics","volume":"4","author":"Liu","year":"2022","journal-title":"Nat Metab"},{"issue":"12","key":"10.1016\/j.metabol.2023.155587_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122660","article-title":"Retinoic acid and its derivatives in skin","volume":"9","author":"Szymanski","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10719-016-9760-5","article-title":"All-trans retinoic acid supplementation prevents cardiac fibrosis and cytokines induced by methylglyoxal","volume":"34","author":"Subramanian","year":"2017","journal-title":"Glycoconj J"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0230","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/0886022X.2021.1910046","article-title":"All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats","volume":"43","author":"Zhong","year":"2021","journal-title":"Ren Fail"},{"issue":"12","key":"10.1016\/j.metabol.2023.155587_bb0235","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1164\/rccm.200606-862OC","article-title":"All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis","volume":"174","author":"Tabata","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.metabol.2023.155587_bb0240","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/labinvest.2013.108","article-title":"All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-beta1\/Smad3 signaling pathway in rats","volume":"93","author":"Song","year":"2013","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/01902148.2011.646052","article-title":"The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice","volume":"38","author":"Dong","year":"2012","journal-title":"Exp Lung Res"},{"issue":"3","key":"10.1016\/j.metabol.2023.155587_bb0250","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbrc.2017.07.122","article-title":"All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling","volume":"491","author":"Leem","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0255","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12455","article-title":"Retinoic acid for treatment of systemic sclerosis and morphea: a literature review","volume":"30","author":"Thomas","year":"2017","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.metabol.2023.155587_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jdermsci.2020.01.002","article-title":"Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: a role in scleroderma","volume":"97","author":"Miura","year":"2020","journal-title":"J Dermatol Sci"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2023.155587_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-8981(99)00123-0","article-title":"Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy","volume":"287","author":"Fujita","year":"1999","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.metabol.2023.155587_bb0270","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103334","article-title":"Proline biosynthesis is a vent for TGFbeta-induced mitochondrial redox stress","volume":"39","author":"Schworer","year":"2020","journal-title":"EMBO J"},{"issue":"6463","key":"10.1016\/j.metabol.2023.155587_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"issue":"51","key":"10.1016\/j.metabol.2023.155587_bb0280","first-page":"161","article-title":"A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis","volume":"10","author":"Pattanaik","year":"2010","journal-title":"Discov Med"},{"issue":"12","key":"10.1016\/j.metabol.2023.155587_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124257","article-title":"Lipid mediators regulate pulmonary fibrosis: potential mechanisms and signaling pathways","volume":"21","author":"Suryadevara","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.metabol.2023.155587_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122730","article-title":"Lysophospholipid-related diseases and PPARgamma signaling pathway","volume":"18","author":"Tsukahara","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2023.155587_bb0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0016-5085(94)95023-7","article-title":"Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon","volume":"106","author":"Lieber","year":"1994","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.metabol.2023.155587_bb0300","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1159\/000373964","article-title":"Plasma phosphatidylcholine alterations in cystic fibrosis patients: impaired metabolism and correlation with lung function and inflammation","volume":"35","author":"Grothe","year":"2015","journal-title":"Cell Physiol Biochem"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523001907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523001907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:33:02Z","timestamp":1758429182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049523001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":60,"alternative-id":["S0026049523001907"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155587","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155587"}}